L-DOPA Association with Reduced Detection of New-Onset GA
March 11, 2025
Levodopa is associated with reduced development of new-onset geographic atrophy in patients with age-related macular degeneration
Learn More
Additional Patents Licensed for Use
March 11, 2025
We are licensed to utilize additional intellectual property in the form of licensed patents as indicated.
Learn More
Role of L-DOPA in Prevention of GA
January 30, 2025
Levodopa is associated with reduced development of new‑onset geographic atrophy (GA) in patients with age‑related macular degeneration. (AMD)
Learn More
US Patent 9,173,862 for MaculaPM™
January 27, 2025
METHODS AND COMPOSITIONS FOR TREATING AND IDENTIFYING COMPOUNDS TO TREAT AGE-RELATED MACULAR DEGENERATION
Learn More
US Patent 9,861,600 for MaculaPM™
January 27, 2025
METHODS AND COMPOSITIONS FOR TREATING AND IDENTIFYING COMPOUNDS TO TREAT AGE-RELATED MACULAR DEGENERATION TREATMENT
Learn More
US Patent 11,969,401 for MaculaPM™
January 27, 2025
COMPOSITIONS AND METHODS FOR TREATING OR LIMITING DEVELOPMENT OF AGE-RELATED MACULAR DEGENERATION
Learn More
European Patent for MaculaPM™
January 27, 2025
Patent for L-Dopa for treating age related macular degeneration.
Learn More
Australian Patent for MaculaPM™
January 27, 2025
Methods and compositions for treating AMD.
Learn More
Warnings Before Taking MaculaPM™
January 27, 2025
As with any supplement, if you are pregnant, nursing, taking medications, have a medical condition or have difficulty swallowing, consult your doctor before use.
Learn More
Different Therapeutic Approaches for AMD
January 27, 2025
This review provides a summary of the current evidence regarding the different treatments aimed at both forms of AMD with particular and greater attention to the dry form.
Learn More
AREDS / AREDS2 Clinical Trials
January 13, 2025
The NEI conducted the Age-Related Eye Disease Study (AREDS) and the follow-on AREDS2 to study cataract and age-related macular degeneration (AMD). Study researchers tested whether taking nutritional supplements could prevent or slow these diseases.
Learn More
New Analysis Shows Benefit of Taking AREDS2 Formula in Late AMD
January 13, 2025
In a new analysis of data, researchers at the National Institutes of Health (NIH) have found that taking a daily supplement containing antioxidant vitamins and minerals slows progression of late-stage dry age-related macular degeneration (AMD).
Learn More